# Clinical trials recruiting in Colorado: 1,879 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,879 trials recruiting or not yet recruiting with a site in Colorado, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Colorado: 1,879 rows for $93.95, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 26 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/colorado

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,879
- Recruiting or not yet: 1,879
- Read on: November 19, 2026

## Trials

The 25 newest of 1,879, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07945041 | Optimizing Acute Care Rehabilitation for Critically Ill Adults | University of Colorado, Denver | Not applicable | Not yet recruiting | ICU Acquired Muscle Weakness, Critical Illness, Functional Impairment, Rehabilitation After Critical Illness | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945041) |
| November 17, 2026 | NCT07941609 | A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLC | AstraZeneca | Phase 2 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941609) |
| November 16, 2026 | NCT07939997 | ctDNA Observational Biomarker Validation Study for Evaluation of Esophageal Squamous Cell Carcinoma | University of Colorado, Denver | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939997) |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 13, 2026 | NCT07935317 | A Study of Tersolisib (LY4064809) and Abemaciclib With Hormone Therapies in Participants With PIK3CA-Mutated Early Breast Cancer | Eli Lilly and Company | Phase 2 | Not yet recruiting | Breast Neoplasms | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935317) |
| November 13, 2026 | NCT07934706 | VA Secure Homes Lethal Means Intervention | VA Office of Research and Development | Not applicable | Not yet recruiting | Suicide, Firearm Injury | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934706) |
| November 13, 2026 | NCT07934680 | Mental Health Link for Veterans Referred to Mental Health Services | VA Office of Research and Development | Not applicable | Not yet recruiting | Depression | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934680) |
| November 12, 2026 | NCT07932002 | Exploring the Extended Efficacy and Initial Use of RUCONEST® in Managing Neurological Symptoms Linked to Infectious Pathogens | IMMUNOe Research Centers | Phase 4 | Recruiting | Post SARS-CoV2 (COVID-19), Post-Viral Fatigue Syndrome, Post-Viral Disorder (Disorder), COVID - 19 | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932002) |
| November 12, 2026 | NCT07931690 | IMPACT-Ready Study | Sponsor not shown (see the record) | Observational | Not yet recruiting | Autism Spectrum Disorder, Neurodevelopmental Disorders | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931690) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931534 | Pediatric Adeno-Tonsillar Hypertrophy Treatment Post-Approval Study | ENTire Medical Ltd. | Not applicable | Not yet recruiting | Airway Obstruction Upper, Tonsillectomy, Adenoidectomy Surgery, Hypertrophy | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931534) |
| November 12, 2026 | NCT07931469 | Real-life Dual-Task Training for Older Adults at Risk to Fall: A Pilot Clinical Trial | Colorado State University | Not applicable | Not yet recruiting | Fall | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931469) |
| November 10, 2026 | NCT07928388 | Continuation Study With Oral MC-1 for Treatment of Patients With PNPO-Deficiency | Medicure | Phase 3 | Recruiting | Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928388) |
| November 6, 2026 | NCT07923045 | A Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of MR-146 in Subjects With Stage I and Stage II Neurotrophic Keratopathy | Viatris Inc. | Phase 1/2 | Recruiting | Neurotrophic Keratopathy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923045) |
| November 6, 2026 | NCT07922239 | Substance Use and Media Preferences | University of Colorado, Denver | Not applicable | Not yet recruiting | Substance Use Behavior, Cannabis Intoxication, Alcohol Intoxication | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922239) |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| November 4, 2026 | NCT07916259 | The Study of Brave-LC LDN Treatment Trial | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | Not yet recruiting | Post-acute COVID-19 Syndrome | 1,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916259) |
| November 4, 2026 | NCT07915479 | Multi-level Intervention to Successfully Transition to Adult Care for Survivors of Childhood and Adolescent Cancers: The BRIDGES-YAS! Study | Georgetown University | Not applicable | Not yet recruiting | Health Care Transition, Survivorship Care, Survivors of Childhood Cancer, Patient Navigation | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915479) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07911150 | Gut-Liver-Muscle Axis in Cancer Cachexia | University of Colorado, Denver | Not applicable | Not yet recruiting | Head & Neck Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911150) |
| November 2, 2026 | NCT07909408 | Psilocybin FCR Early-Stage Breast Cancer | NYU Langone Health | Phase 2 | Not yet recruiting | Early-stage Breast Cancer, Fear of Cancer Recurrence, Anxiety, Depression | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909408) |
| October 29, 2026 | NCT07903311 | Iron Repletion in Cystic Fibrosis | University of Michigan | Phase 4 | Not yet recruiting | Cystic Fibrosis, Iron Deficiencies, Iron Deficiency Diseases | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903311) |
| October 29, 2026 | NCT07902817 | A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy | Jade Biosciences, Inc. | Phase 3 | Recruiting | IgA Nephropathy (IgAN) | 480 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902817) |
| October 28, 2026 | NCT07901608 | Philips Inflationary-Based Non-Invasive Blood Pressure Validation Study | Philips Clinical & Medical Affairs Global | Observational | Recruiting | Blood Pressure Measurement | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901608) |
| October 27, 2026 | NCT07897851 | The Orientation Intervention to Rapid Response Teams (ORIENT-RRT) Study: A Quasi-Experimental Study | University of Colorado, Denver | Not applicable | Recruiting | Deterioration, Clinical | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897851) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Children's Hospital Colorado | Denver | 178 |
| University of Colorado Anschutz Medical Campus | Aurora | 100 |
| University of Colorado | Aurora | 96 |
| University of Colorado Hospital | Aurora | 62 |
| Colorado Blood Cancer Institute | Denver | 59 |
| UCHealth University of Colorado Hospital | Aurora | 54 |
| University of Colorado Cancer Center | Aurora | 45 |
| Medical Center of the Rockies | Loveland | 44 |
| University of Colorado Denver | Aurora | 40 |
| Rocky Mountain Cancer Centers-Penrose | Colorado Springs | 40 |
| UCHealth Greeley Hospital | Greeley | 39 |
| Penrose-Saint Francis Healthcare | Colorado Springs | 39 |
| Longmont United Hospital | Longmont | 39 |
| Poudre Valley Hospital | Fort Collins | 38 |
| National Jewish Health | Denver | 38 |
| UCHealth Memorial Hospital Central | Colorado Springs | 37 |
| Saint Mary Corwin Medical Center | Pueblo | 37 |
| Cancer Care and Hematology-Fort Collins | Fort Collins | 36 |
| Rocky Mountain Cancer Centers | Denver | 35 |
| Mercy Medical Center | Durango | 35 |
| Rocky Mountain Regional VA Medical Center, Aurora, CO | Aurora | 34 |
| Memorial Hospital North | Colorado Springs | 33 |
| Saint Francis Cancer Center | Colorado Springs | 32 |
| CommonSpirit Cancer Center Mercy | Durango | 31 |
| AdventHealth Porter | Denver | 30 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 9 |
| Phase 1 | 165 |
| Phase 1/2 | 148 |
| Phase 2 | 309 |
| Phase 2/3 | 61 |
| Phase 3 | 480 |
| Phase 4 | 55 |
| Not applicable | 350 |
| Observational | 302 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 78 |
| Breast Neoplasms | 63 |
| Neoplasms | 62 |
| Colorectal Neoplasms | 56 |
| Neoplasm Metastasis | 50 |
| Lung Neoplasms | 44 |
| Ovarian Neoplasms | 42 |
| Prostatic Neoplasms | 41 |
| Multiple Myeloma | 39 |
| Melanoma | 34 |
| Endometrial Neoplasms | 33 |
| Recurrence | 31 |
| Diabetes Mellitus, Type 1 | 30 |
| Obesity | 29 |
| Pancreatic Neoplasms | 27 |
| Squamous Cell Carcinoma of Head and Neck | 26 |
| Heart Failure | 26 |
| Leukemia, Myeloid, Acute | 24 |
| Urinary Bladder Neoplasms | 23 |
| Triple Negative Breast Neoplasms | 23 |
| Motor Activity | 23 |
| Depression | 23 |
| Stomach Neoplasms | 23 |
| Diabetes Mellitus, Type 2 | 20 |
| Cardiovascular Diseases | 20 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Colorado, Denver | 238 |
| National Cancer Institute (NCI) | 43 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 43 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 38 |
| VA Office of Research and Development | 34 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 34 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 32 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 29 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 24 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 23 |
| Children's Oncology Group | 23 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 21 |
| Alliance for Clinical Trials in Oncology | 19 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 18 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 18 |
| Colorado State University | 18 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 18 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 17 |
| SWOG Cancer Research Network | 17 |
| NRG Oncology | 16 |
| University of Colorado, Boulder | 16 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 13 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 12 |
| Yale University | 11 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 11 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Colorado

- [Urology practices in Colorado, United States](https://specstream.ai/data/businesses/urology-practices/colorado-united-states)
- [Damage restoration companies in Colorado, United States](https://specstream.ai/data/businesses/damage-restoration-companies/colorado-united-states)
- [Latin American restaurants in Colorado, United States](https://specstream.ai/data/businesses/latin-american-restaurants/colorado-united-states)
- [Sleep medicine clinics in Colorado, United States](https://specstream.ai/data/businesses/sleep-medicine-clinics/colorado-united-states)
- [Cajun and Creole restaurants in Colorado, United States](https://specstream.ai/data/businesses/cajun-and-creole-restaurants/colorado-united-states)
- [Hotels in Colorado, United States](https://specstream.ai/data/businesses/hotels/colorado-united-states)
